Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and ... Three glomeruli exhibited segmental fibrinoid necrosis. Moderate ...

Higher sKlotho levels are linked to lower CKD prevalence in individuals with diabetes and hypertension, but not in those without hypertension. The study suggests a synergistic effect between low ...

Hypertension remains a significant public health concern worldwide, contributing to a substantial burden of cardiovascular disease and related mortality and leading to an annual health care cost ...

By creating a new laboratory model for studying these conditions, the team treated hypertension and aortic aneurysms by targeting ... Mar. 27, 2025 — A research team has investigated structural ...

HemiClor is expected to be available in pharmacies starting in May 2025. The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the ...

SAN DIEGO — Patients with cirrhosis treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant reductions in a range of portal hypertension complications and all-cause ...

Patients with untreated or uncontrolled hypertension who started antihypertensive monotherapy in the first month after diagnosis were more likely to achieve blood pressure (BP) control at 6 months ...

Hypertension affects nearly half of American adults, often developing silently until it leads to serious health complications. While medication remains a cornerstone of treatment for many, growing ...

"This study was designed to look at the impact of a novel medication in lowering blood pressure for individuals whose hypertension is inadequately controlled by current standard medications," said ...

About 1.28 billion people around the world live with high blood pressure, or hypertension. Hypertension can increase a person’s risk for several medical conditions, including dementia.